Full Press Release Details
AUNA ANNOUNCES PRICING OF
ADDITIONAL 10.000% SENIOR SECURED NOTES DUE 2029
Luxembourg, May 7, 2025 - Auna
S.A. (NYSE: AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru
and Colombia, today announced the pricing of its previously announced offering of an additional $62.1 million in aggregate principal
amount of its 10.000% senior secured notes (the "Additional Notes") in a private offering to qualified institutional buyers
in accordance with Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States
to non-U.S. persons in accordance with Regulation S under the Securities Act.
The Additional Notes will be an issuance of Auna's
existing 10.000% senior secured notes due 2029 and will be issued as additional notes under the indenture dated as of December 18, 2023
(as amended and supplemented, the "Indenture") pursuant to which Auna previously issued US$ 310,837,161 aggregate principal
amount of 10.000% senior secured notes due 2029 (the "Initial Notes"). The Additional Notes will be of the same class and
series as, and otherwise identical to, the Initial Notes other than with respect to the date of issuance, issue price and first interest
payment date. The Additional Notes will be fully and unconditionally guaranteed on a senior secured basis by certain of the Company's
The proceeds from the Additional Notes offering
will be used by the Company to partially prepay indebtedness under the credit agreement, dated as of November 10, 2023, and to pay related
interests, fees and expenses.
This press release does not constitute an offer
to sell or a solicitation of an offer to buy these securities, nor will there be any sale of these securities, in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state
or jurisdiction. The Additional Notes and related guarantees have not been registered under the Securities Act, or any applicable state
securities laws, and were offered only to qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act and
outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. Unless so registered, the Additional
Notes and related guarantees may not be offered or sold in the United States except pursuant to an exemption from the registration requirements
of the Securities Act and any applicable state securities laws.
Auna is a leading healthcare platform in Latin
America with operations in Mexico, Peru and Colombia, prioritizing prevention and concentrating on high-complexity diseases that contribute
the most to healthcare expenditures. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering
in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America s largest modern
platforms that consists of a horizontally integrated
network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As
of December 31, 2024, Auna's network included 31 healthcare network facilities, consisting of hospitals, outpatient, prevention
and wellness facilities with a total of 2,323 beds, and 1.4 million healthcare plans.
more information visit www.aunainvestors.com
Investor Relations Contact
Cautionary Statement on Forward-Looking Statements
This press release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often are proceeded by words such
as "believes," "expects," "may," "anticipates," "plans," "intends,"
"assumes," "will" or similar expressions. The forward-looking statements contained herein include statements about
the Company's Additional Notes offering and its intended use of proceeds therefrom. These expectations may or may not be realized.
Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, Auna's business and
operations involve numerous risks and uncertainties, many of which are beyond the control of Auna, which could result in Auna's
expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of Auna.
Some of the factors that could cause future results to materially differ from recent results or those projected in forward-looking statements
are described in Auna's filings with the United States Securities and Exchange Commission, including its annual report filed on
Form 20-F on April 10, 2025.
The forward-looking statements are made only as
of the date hereof, and Auna does not undertake any obligation to (and expressly disclaims any obligation to) update any forward-looking
statements to reflect events or circumstances after the date such statements were made, or to reflect the occurrence of unanticipated
events. In light of the risks and uncertainties described above, and the potential for variation of actual results from the assumptions
on which certain of such forward-looking statements are based, investors should keep in mind that the results, events or developments
disclosed in any forward-looking statement made in this document may not occur, and that actual results may vary materially from those
described herein, including those described as anticipated, expected, targeted, projected or otherwise.